Quarterly report pursuant to Section 13 or 15(d)

Stock Options - Schedule of Stock Option Activity (Details)

v3.21.2
Stock Options - Schedule of Stock Option Activity (Details) - $ / shares
 3 Months Ended 12 Months Ended
Mar. 31, 2021
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]    
Number of Options, Outstanding Beginning 3,661,162 2,267,571
Number of Options, Granted [1] 2,523,427
Number of Options, Forfeited or expired (1,129,836)
Number of Options, Outstanding Ending 3,661,162
Number of Options, Exercisable Ending 1,004,376 877,122
Weighted Average Exercise Price, Outstanding Beginning $ 0.066 $ 0.061
Weighted Average Exercise Price, Granted 0.095
Weighted Average Exercise Price, Forfeited or expired 0.120
Weighted Average Exercise Price, Outstanding Ending 0.066
Weighted Average Exercise Price, Exercisable Ending $ 0.026 $ 0.016
[1] On July 29, 2020 (the "Commitment Date"), the Company held its Annual General Meeting of Shareholders, at which the shareholders of the Company approved compensation packages for two officers that include inter alia the Company is obligated to grant of 2,545,083 stock options which are exercisable into the same number of shares of common stock at an exercise price of $0.095 per share and shall become vested quarterly over a 5-year period from its grant date. At the Commitment Date, the Company by assistance of third-party appraiser measured the fair value of the stock options in total amount of $206 by using Black-Scholes-Merton pricing model in which the assumptions that have been used are as follows: expected dividend yield of 0%; risk-free interest rate of 0.25%; expected volatility of 131.9%, and stock options exercise period based upon the stated terms. In addition, as one-time bonus as compensation for uncompensated efforts to the Commitment Date, the Company is obligated to grant fully vested shares equal to $275 based on the fair market value of the Company's shares as of July 28, 2020. The Company recorded stock-based compensation expense of this amount as part of "General and Administrative Expenses" line in operations in the accompanying consolidated statement of operations during the year ended December 31, 2020. Moreover, upon consummation of the Company's planned public offering, 30,000,000 restricted stock units' bonuses will be granted to the aforesaid officers. At the Commitment Date, December 31, 2020 and March 31, 2021, the likelihood that the Performance Milestone for consummation of the Company's planned public offering was not considered as probable. Thus, during the year ended December 31, 2020 and the period of three months ended March 31, 2021, stock-based compensation expense has not been recorded with respect to the Performance Milestone. During the year ended December 31, 2020 and the period of three months ended March 31, 2021, the Company recorded stock-based compensation expense amounting to $331 and $23, respectively, as part of "General and Administrative Expenses" line in operations in the accompanying consolidated statement of operations.